LGND
NASDAQ · Pharmaceuticals
Ligand Pharmaceuticals
$299.04
+0.63 (+0.21%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+79.32%
YTD
+57.30%
Open$296.95
Previous Close$298.41
Day High$303.41
Day Low$296.37
52W High$326.63
52W Low$163.45
Volume—
Avg Volume214.4K
Market Cap5.63B
P/E Ratio28.57
EPS$9.40
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$193.47
Above
SMA 200
$162.08
Above
RSI (14)
38.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-89.4% upside
Current
$299.04
$299.04
Target
$31.56
$31.56
$18.80
$31.56 avg
$35.41
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 262.55M | 236.59M | 944.72M |
| Net Income | 121.88M | 98.85M | 258.92M |
| Profit Margin | 46.4% | 44.1% | 27.4% |
| EBITDA | 72.19M | 61.80M | 346.84M |
| Free Cash Flow | — | — | 167.31M |
| Rev Growth | +11.0% | +11.0% | +8.5% |
| Debt/Equity | 0.44 | 0.44 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,181.89 | +2.68% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $270.68 | +0.56% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $147.98 | -0.07% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.41 | +0.82% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.50 | +0.57% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $70.27 | -1.87% | 11.5 | 30.15B |